DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
Van Assche G, Sandborn WJ, Feagan BG et al.
Daclizumab, a humanised monoclonal antibody to the interleukin 2 receptor (CD25), for the treatment of moderately to severely active ulcerative colitis: a randomised, double blind, placebo controlled, dose ranging trial.
Gut 2006;
55: 1568-1574
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.